These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18611099)

  • 1. Breakthrough pain in the management of chronic persistent pain syndromes.
    Webster LR
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S116-22. PubMed ID: 18611099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutic management of breakthrough pain in patients with chronic persistent pain.
    Fishbain DA
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S123-8. PubMed ID: 18611100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of breakthrough pain.
    McCarberg BH
    Pain Med; 2007; 8 Suppl 1():S8-13. PubMed ID: 17280601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study.
    Højsted J; Nielsen PR; Eriksen J; Hansen OB; Sjøgren P
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1290-6. PubMed ID: 16999839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and diagnosis of breakthrough pain.
    Payne R
    Pain Med; 2007; 8 Suppl 1():S3-7. PubMed ID: 17280600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
    Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
    Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain.
    Portenoy RK; Bennett DS; Rauck R; Simon S; Taylor D; Brennan M; Shoemaker S
    J Pain; 2006 Aug; 7(8):583-91. PubMed ID: 16885015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study.
    Weinstein SM; Messina J; Xie F
    Cancer; 2009 Jun; 115(11):2571-9. PubMed ID: 19373888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics.
    Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
    J Opioid Manag; 2010; 6(2):97-108. PubMed ID: 20481174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current developments in opioid therapy for management of cancer pain.
    de Leon-Casasola OA
    Clin J Pain; 2008 May; 24 Suppl 10():S3-7. PubMed ID: 18418225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and management of breakthrough pain in cancer.
    Zeppetella G
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):1-6. PubMed ID: 19365156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variation of breakthrough pain in cancer patients.
    Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
    Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management.
    Fine PG; Mahajan G; McPherson ML
    Pain Med; 2009 Jul; 10 Suppl 2():S79-88. PubMed ID: 19691687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough pain in children with cancer.
    Friedrichsdorf SJ; Finney D; Bergin M; Stevens M; Collins JJ
    J Pain Symptom Manage; 2007 Aug; 34(2):209-16. PubMed ID: 17553659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in pain management at the end of life.
    Miller KE; Miller MM; Jolley MR
    Am Fam Physician; 2001 Oct; 64(7):1227-34. PubMed ID: 11601805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study.
    Gatti A; Mediati RD; Reale C; Cuomo A; Vellucci R; Russo G; Costantini A; Canneti A; Luzi M; Mammucari M; Sabato AF
    Adv Ther; 2012 May; 29(5):464-72. PubMed ID: 22622488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.
    Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
    J Opioid Manag; 2010; 6(2):109-16. PubMed ID: 20481175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl buccal tablet: faster rescue analgesia for breakthrough pain?
    Lecybyl R; Hanna M
    Future Oncol; 2007 Aug; 3(4):375-9. PubMed ID: 17661711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.